Eli Lilly given inexperienced mild in US to regard sleep problem with weight-loss drug Monetary TimesF.D.A. Approves Weight Loss Drug to Deal with Obstructive Sleep Apnea The New York TimesFDA Approves First Medicine for Obstructive Sleep Apnea FDA.govFDA approves weight-loss drug Zepbound for obstructive sleep apnea CNNFDA approves Zepbound® (tirzepatide) as the primary and handiest prescription medication for moderate-to-severe obstructive sleep apnea in adults with weight problems Traders | Eli Lilly and Corporate
